Author:
Bartlett J M S, ,Nielsen T O,Gao D,Gelmon K A,Quintayo M A,Starczynski J,Han L,Burnell M J,Levine M N,Chen B E,Shepherd L E,Chapman J W
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Allen T, van TM, Iyengar P, Jothy S, Post M, Tsao MS, Lobe CG (2006) Grg1 acts as a lung-specific oncogene in a transgenic mouse model. Cancer Res 66 (3): 1294–1301.
2. Bartlett JM, A'Hern R, Piper T, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Bliss JM, Ellis P, Barrett-Lee PJ (2013) Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer. Breast Cancer Res Treat 138 (3): 773–781.
3. Bartlett JMS, Brookes CL, Robson T, van de Velde CJH, Billingham LJ, Campbell FM, Grant M, Hasenburg A, Hille ET, Kay C, Kieback DG, Putter H, Markopoulos C, Kranenbarg EM, Mallon EA, Dirix L, Seynaeve C, Rea D (2011) Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational Trial. J Clin Oncol 29 (12): 1531–1538.
4. Basu GD, Ghazalpour A, Arguello D, Ashfaq R, Gatalica Z, McGinniss MJ, Blevins R, Danenberg KD (2012) Frequency of TLE3 over-expression in breast carcinoma subtypes including a large cohort of triple negative patients. J Clin Oncol In 2012 ASCO Annual Meeting. Alexandria, VA, USA.
5. Bedard PL, Di Leo A, Piccart-Gebhart MJ (2010) Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat Rev Clin Oncol 7 (1): 22–36.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献